Loading...
Chemical structure of CPI-268456

GC43320

CPI-268456

Also known as 2-[(4S)-8-chloro-6-(4-chlorophenyl)-1-methyl-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide

CPI-268456 (compound 141) is a potent BRD4 inhibitor with an IC50 of ＜0·5 μM

ChemicalCAS1380087-86-4MW400.3FormulaC20H15Cl2N3O2
CAS number
1380087-86-4
Molecular weight
400.3
Formula
C20H15Cl2N3O2
Solubility
DMF： 30 mg/ml,DMF：PBS (pH 7·2) (1：3)： 0·25 mg/ml,DMSO： 20 mg/ml,Ethanol： 20 mg/ml
InChIKey
RKYPLOAYXFDLOF-INIZCTEOSA-N
Catalogue number
GC43320
Brand
GLPBIO
Computed properties PubChem CID 57389997 · XLogP 3.7 · TPSA 81.5 Ų · H-bond donors 1
XLogP
3.7
TPSA
81.5 Ų
H-bond donors
1
H-bond acceptors
4
Rotatable bonds
3
Heavy atoms
27

SMILES CC1=NOC2=C1C3=C(C=C(C=C3)Cl)C(=N[C@H]2CC(=O)N)C4=CC=C(C=C4)Cl

Computed descriptors from PubChem (CID 57389997), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.